Artelo Biosciences to Present at the Annual Investival Showcase in London
November 14 2019 - 8:00AM
Artelo Biosciences, Inc. (NASDAQ: ARTL), a
clinical stage biopharmaceutical company developing therapeutics
that modulate the endocannabinoid system, today announced that it
will be presenting at the Annual Investival Showcase to be held on
November 19, 2019 at the Waldorf Hilton Hotel in London, England.
Gregory D. Gorgas, President and Chief Executive
Officer of Artelo Biosciences, is scheduled to present on Tuesday,
November 19th at 11:30 a.m., GMT, with one-on-one meetings to be
held throughout the conference.
LSX’s Investival Showcase continues its
exclusive partnership with global investment bank Jefferies, with
the showcase co-located with the Jefferies 2019 London Healthcare
Conference. It offers the opportunity for a greater proportion of
private and smaller cap public companies to be a part of the
biggest week in European life sciences investment. The showcase
provides the opportunity to pitch, profile and connect with
investment partners brought together in London by both LSX, and
Jefferies.
About Artelo BiosciencesArtelo
Biosciences, Inc. is a San Diego-based biopharmaceutical company
dedicated to the development and commercialization of proprietary
therapeutics targeting the endocannabinoid system. Artelo is
rapidly advancing a portfolio of broadly applicable product
candidates designed to address significant unmet needs in multiple
diseases and conditions, including anorexia, cancer, pain, and
inflammation. Led by proven biopharmaceutical executives
collaborating with highly respected researchers and technology
experts, the Company applies leading edge scientific, regulatory,
and commercial discipline to develop high-impact therapies. More
information is available at www.artelobio.com and Twitter:
@ArteloBio.
Investor Relations
Contact:Crescendo Communications, LLCTel:
212-671-1020Email: ARTL@crescendo-ir.com
Artelo Biosciences (NASDAQ:ARTLW)
Historical Stock Chart
From Jul 2024 to Aug 2024
Artelo Biosciences (NASDAQ:ARTLW)
Historical Stock Chart
From Aug 2023 to Aug 2024